Reaction
Skin Striae reporting signals
As of the last recalculation, Skin Striae appears in 1,471 FAERS reports alongside 30 co-occurring drug terms. The strongest observed disproportionality signal is RITONAVIR 100 MG (PRR 30.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ritonavir 100 Mg | 31 | 30.0 | 30.0 |
| Clobetasol Propionate Ointment Usp, 0.05% | 19 | 26.4 | 26.5 |
| Clobetasol Propionate | 19 | 26.3 | 26.4 |
| Darunavir | 23 | 21.8 | 21.9 |
| Ritonavir | 43 | 21.4 | 21.5 |
| Budesonide | 73 | 18.4 | 18.4 |
| Anakinra | 17 | 14.7 | 14.7 |
| Raltegravir | 13 | 11.2 | 11.2 |
| Fluticasone Propionate Nasal | 23 | 10.9 | 10.9 |
| Daspone | 7 | 10.2 | 10.2 |
| Dapsone Gel, 5% | 7 | 10.2 | 10.2 |
| Temozolomide | 14 | 9.5 | 9.5 |
| Atazanavir | 9 | 8.9 | 8.9 |
| Asfotase Alfa | 6 | 8.5 | 8.5 |
| Guanfacine | 4 | 7.2 | 7.2 |
| Pegaspargase | 6 | 7.0 | 7.0 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 5 | 5.7 | 5.7 |
| Pegvaliase-Pqpz | 3 | 5.2 | 5.2 |
| Medroxyprogesterone Acetate | 18 | 5.2 | 5.2 |
| Ixekizumab | 13 | 5.0 | 5.0 |
| Bimekizumab | 7 | 4.7 | 4.7 |
| Etonogestrel | 15 | 4.5 | 4.5 |
| Guselkumab | 11 | 4.4 | 4.4 |
| Paliperidone | 7 | 4.3 | 4.3 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 3 | 4.2 | 4.2 |
| Isotretinoin | 13 | 3.7 | 3.7 |
| Abaloparatide | 7 | 3.4 | 3.4 |
| Somatropin | 16 | 3.1 | 3.1 |
| Dupilumab | 54 | 1.6 | 1.6 |
| Adapalene | 3 | 0.2 | 0.2 |